LARA SHLEEF: Open Payments
NPI 1013330992 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 10 payments from 8 companies in 2025. Trend: 2023 $171 · 2024 $82 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Novo Nordisk Inc | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| ABBVIE INC. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Almatica Pharma LLC | 1 | $13 |
Products named: AUSTEDO XR, CAPLYTA, MAVYRET, SPRAVATO, OTEZLA, AIRSUPRA, LOREEV XR.
Industry payments across AZ — which companies pay providers there.
